-
1
-
-
77950919863
-
Treatment with IFN-{alpha}, -{beta}, or -{gamma} is associated with collapsing focal segmental glomerulosclerosis
-
G.S. Markowitz, S.H. Nasr, M.S. Stokes, V.D. D'Agati Treatment with IFN-{alpha}, -{beta}, or -{gamma} is associated with collapsing focal segmental glomerulosclerosis Clin J Am Soc Nephrol 5 4 2010 607 615
-
(2010)
Clin J Am Soc Nephrol
, vol.5
, Issue.4
, pp. 607-615
-
-
Markowitz, G.S.1
Nasr, S.H.2
Stokes, M.S.3
D'Agati, V.D.4
-
2
-
-
0036236110
-
Immune-mediated complications during interferon therapy in hematological patients
-
P. Raanani, I. Ben Bassat Immune-mediated complications during interferon therapy in hematological patients Acta Haematol 107 3 2002 133 144
-
(2002)
Acta Haematol
, vol.107
, Issue.3
, pp. 133-144
-
-
Raanani, P.1
Ben Bassat, I.2
-
3
-
-
17544373868
-
Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with hepatitis C
-
T.B. Niewold, W.I. Swedler Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with hepatitis C Clin Rheumatol 24 2 2005 178 181
-
(2005)
Clin Rheumatol
, vol.24
, Issue.2
, pp. 178-181
-
-
Niewold, T.B.1
Swedler, W.I.2
-
4
-
-
33846136080
-
Full-house nephropathy in a patient with negative serology for lupus
-
E. Baskin, P.I. Agras, N. Menekse, H. Ozdemir, N. Cengiz Full-house nephropathy in a patient with negative serology for lupus Rheumatol Int 27 3 2007 281 284
-
(2007)
Rheumatol Int
, vol.27
, Issue.3
, pp. 281-284
-
-
Baskin, E.1
Agras, P.I.2
Menekse, N.3
Ozdemir, H.4
Cengiz, N.5
-
5
-
-
84855604535
-
Type i interferon signature is high in lupus and neuromyelitis optica but low in multiple sclerosis
-
X. Feng, N.P. Reder, M. Yanamandala Type I interferon signature is high in lupus and neuromyelitis optica but low in multiple sclerosis J Neurol Sci 313 1-2 2012 48 53
-
(2012)
J Neurol Sci
, vol.313
, Issue.12
, pp. 48-53
-
-
Feng, X.1
Reder, N.P.2
Yanamandala, M.3
-
6
-
-
84863583259
-
Large-scale analysis of tumor necrosis factor α levels in systemic lupus erythematosus
-
C.E. Weckerle, D. Mangale, B.S. Franek Large-scale analysis of tumor necrosis factor α levels in systemic lupus erythematosus Arthritis Rheum 64 9 2012 2947 2952
-
(2012)
Arthritis Rheum
, vol.64
, Issue.9
, pp. 2947-2952
-
-
Weckerle, C.E.1
Mangale, D.2
Franek, B.S.3
-
7
-
-
0345359586
-
Induction of clinical autoimmune disease by therapeutic interferon-alpha
-
C. Gota, L. Calabrese Induction of clinical autoimmune disease by therapeutic interferon-alpha Autoimmunity 36 8 2003 511 518
-
(2003)
Autoimmunity
, vol.36
, Issue.8
, pp. 511-518
-
-
Gota, C.1
Calabrese, L.2
-
8
-
-
62749179036
-
Anti-double stranded DNA and lupus syndrome induced by interferon-β therapy in a patient with multiple sclerosis
-
B. Bonaci-Nikolic, I. Jeremic, S. Andrejevic, M. Sefik-Bukilica, N. Stojsavljevic, J. Drulovic Anti-double stranded DNA and lupus syndrome induced by interferon-β therapy in a patient with multiple sclerosis Lupus 18 1 2009 78 80
-
(2009)
Lupus
, vol.18
, Issue.1
, pp. 78-80
-
-
Bonaci-Nikolic, B.1
Jeremic, I.2
Andrejevic, S.3
Sefik-Bukilica, M.4
Stojsavljevic, N.5
Drulovic, J.6
-
9
-
-
0030811129
-
Microglial production of TNF alpha is induced by activated T lymphocytes Involvement of VLA-4 and inhibition by interferon beta-1b
-
S. Chabot, G. Williams, V.W. Yong Microglial production of TNF alpha is induced by activated T lymphocytes Involvement of VLA-4 and inhibition by interferon beta-1b J Clin Invest 100 3 1997 604 612
-
(1997)
J Clin Invest
, vol.100
, Issue.3
, pp. 604-612
-
-
Chabot, S.1
Williams, G.2
Yong, V.W.3
-
10
-
-
0032828063
-
Influence of interferon beta-1a dose frequency on PBMC cytokine secretion and biological effect markers
-
L.E. Rothuizen, T. Buclin, F. Spertini Influence of interferon beta-1a dose frequency on PBMC cytokine secretion and biological effect markers J Neuroimmunol 99 1 1999 131 141
-
(1999)
J Neuroimmunol
, vol.99
, Issue.1
, pp. 131-141
-
-
Rothuizen, L.E.1
Buclin, T.2
Spertini, F.3
-
11
-
-
0029950889
-
Interferon-beta 1b treatment decreases tumor necrosis factor-alpha and increases interleukin-6 production in multiple sclerosis
-
S.A. Brod, G.D. Marshall Jr, E.M. Henninger, S. Sriram, M. Khan, J.S. Wolinsky Interferon-beta 1b treatment decreases tumor necrosis factor-alpha and increases interleukin-6 production in multiple sclerosis Neurology 46 6 1996 1633 1638
-
(1996)
Neurology
, vol.46
, Issue.6
, pp. 1633-1638
-
-
Brod, S.A.1
Marshall, Jr.G.D.2
Henninger, E.M.3
Sriram, S.4
Khan, M.5
Wolinsky, J.S.6
-
12
-
-
0018472522
-
Delay in growth and the development of nephritis in rats treated with interferon preparations in the neonatal period
-
I. Gresser, L. Morel-Maroger, F. Chatelet Delay in growth and the development of nephritis in rats treated with interferon preparations in the neonatal period Am J Pathol 95 2 1979 329 346
-
(1979)
Am J Pathol
, vol.95
, Issue.2
, pp. 329-346
-
-
Gresser, I.1
Morel-Maroger, L.2
Chatelet, F.3
-
13
-
-
0037451124
-
Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice
-
M.L. Santiago-Raber, R. Baccala, K.M. Haraldsson Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice J Exp Med 197 6 2003 777 788
-
(2003)
J Exp Med
, vol.197
, Issue.6
, pp. 777-788
-
-
Santiago-Raber, M.L.1
Baccala, R.2
Haraldsson, K.M.3
-
14
-
-
79961214569
-
Membranoproliferative glomerulonephritis: Pathogenetic heterogeneity and proposal for a new classification
-
S. Sethi, F.C. Fervenza Membranoproliferative glomerulonephritis: pathogenetic heterogeneity and proposal for a new classification Semin Nephrol 31 4 2011 341 348
-
(2011)
Semin Nephrol
, vol.31
, Issue.4
, pp. 341-348
-
-
Sethi, S.1
Fervenza, F.C.2
-
15
-
-
84864554927
-
Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies
-
A. Servais, L.H. Noël, L.T. Roumenina Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies Kidney Int 82 4 2012 454 464
-
(2012)
Kidney Int
, vol.82
, Issue.4
, pp. 454-464
-
-
Servais, A.1
Noël, L.H.2
Roumenina, L.T.3
-
16
-
-
35848935010
-
Interferon-beta reduces proteinuria in experimental glomerulonephritis
-
S.C. Satchell, O. Buchatska, S.B. Khan Interferon-beta reduces proteinuria in experimental glomerulonephritis J Am Soc Nephrol 18 11 2007 2875 2884
-
(2007)
J Am Soc Nephrol
, vol.18
, Issue.11
, pp. 2875-2884
-
-
Satchell, S.C.1
Buchatska, O.2
Khan, S.B.3
-
17
-
-
33144466289
-
Interferon-beta: A therapeutic for autoimmune lupus in MRL-Faslpr mice
-
A. Schwarting, K. Paul, S. Tschirner Interferon-beta: a therapeutic for autoimmune lupus in MRL-Faslpr mice J Am Soc Nephrol 16 11 2005 3264 3272
-
(2005)
J Am Soc Nephrol
, vol.16
, Issue.11
, pp. 3264-3272
-
-
Schwarting, A.1
Paul, K.2
Tschirner, S.3
|